Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Linda L has Covid … confirmed
I doubt updating clinicaltrials is top of mind.
It’s been a few years since we really got excited about stumbling upon updates there.
My dear wife will be suspicious when she finds out I only slept for four hours last night.
Marjorie Sexton!!!
“…right here right now…”.
- Jesus Jones
…for two minutes…
Science Special Issue cover
#DCVax$NWBO https://t.co/mZA1ZtglpY
— Linda Powers Alter Ego (@_NWBO_) April 29, 2022
“Suddenly”?
I suppose it depends on perspective.
Rick and Marty didn’t even find wood in the can this week.
Next week is SEASON FINALE of The Curse of Oak Island.
I’m not connecting the two. Yet…
Have a good weekend everyone.
His direct email address can be “found” on the internet. I’m sure you’ve seen it before.
“withholding the article publication” sounds incompatible with scientific methods.
“Any speculation on any events occurring this week and when?!?
Rick and Marty Lagina will be on with a new episode of “Curse of Oak Island” on Tuesday. They started a new can and I’m thinking they may find mud and some wood in this one too. Will they find gold? We shall soon find out.
Northwest Biotherapeutics will be busy working towards publishing trial results in a peer-reviewed journal. Will they end the week one week closer to that? We shall soon find out. Friday, if not sooner.
Re: secret signals
I’d love to see RWE of signals correlated to subsequent action - in the form of actual PR, actual volume chances, or actual price movement.
I suspect there is none.
ccie
“…decide if you want to hold or sell your current position.”
Or add hand over fist.
There’s that option too.
Come on Lets Leak a Little
Cuppy, handle-y.
Don't forget "expected"
“… patience beaten the *&^! Into you…”
; )
…patience has been literally beaten out of us.
From where this shareholder sits, anyway.
ccie
Really?
Do some work yourself.
So let me see if I have this straight. Between zero and plural is singular, one, a patient. As in the first.
Not rocket science. And certainly no eye roll - neither plural nor singular - needed.
Thanks, FeMike!!!
“… how much volume …”
I know you didn’t ask me, but I am anticipating volume may be enough that we should check our car keys at the door and plan to spend the night just in case.
Cheers.
“ Red by the eod.”
I’m sorry, to what we’re you referring this time?
the vaccine is identified as ADCV (“Autologous Dendritic Cell Vaccine”).
“ In 1-10 , what is missing ?”
I think you again found them all!
“ It will be RED by the end of the day …”
To what were you referring?
“What is missing?”
You got them all.
I bought at .63, .73, and .75, before and on 12/10.
There was news. on 12/21.
I am your manipulator.
“ First, we intend to strengthen our leadership in oncology broadly and leverage that position for sustained long-term success. We’ve done an excellent job of establishing KEYTRUDA as a foundational therapy, and we intend to maximize its opportunity and patient impact. In addition, we have an expanding portfolio of commercial and developmental oncology assets beyond KEYTRUDA, which offer meaningful growth opportunities beyond 2028.”
- Merck CEO Rob Davis. Q4 2021 Earnings Conference Call
“why does this article not mention naked short selling?”
Is that a rhetorical question???
Lol
UCLA: we’re gonna write a paper.
Journals: not any more you’re not!
“… large Dolly Parton…”
Redundant. : )
Thaaaaank you.
An over-repeated 2-word reply to argue a point is nearly as frustrating to read as is a copy and paste of someone else’s post just minutes after it was posted so that it’s easily accessible when you are ready to put it behind your paywall.
“eye roll”
should it ever happen when your eye roll is in the 12 o’clock position that you see a rocket lifting off, please let us know.
ae kusterer Thursday, 02/10/22 08:01:16 AM
Re: None 0
Post # of 442834
Basilisk Wednesday, 02/09/22 11:03:52 PM
Re: None 0
Post #
442757
of 442814
PDS Biotechnology, focused on dendritic cell-based therapy, is in three Phase 2 trials of its Versamune platform using specialized lipids and HPV-related cancer antigens in conjunction with Keytruda to stimulate tge production of CD8+ T-cells. The Versamune platform does not follow NWBO's path of growing dendritic cells, but relies on those already existing in the body. Merck is exploring more than one dendritic cell approach to prolong Keytruda's use in oncology.
in a quiet period…on advice of counsel